{
  "ticker": "SOM",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973704",
  "id": "02973704",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250729",
  "time": "0915",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250729/pdf/06m7s8nq34m3cg.pdf",
  "summary": "### **SomnoMed Limited \u2013 Appendix 4C (Q4 FY25) Summary**  \n\n- **Closing Cash Balance**: **A$17.3M** (vs. A$18.7M prior quarter).  \n- **Operating Cash Flow (Qtr)**: **A$1.4M** (receipts: A$29.3M, payments: A$27.9M).  \n- **Investing Cash Flow (Qtr)**: **A$1.7M outflow** (mainly capex: A$1.2M, IP: A$0.5M).  \n- **Financing Cash Flow (Qtr)**: **A$0.3M outflow** (loan repayments: A$0.3M).  \n- **Debt Facilities**:  \n  - **Drawn**: **A$0.8M** (EUR-denominated govt-backed loans in France/Germany).  \n  - **Undrawn**: **Nil**.  \n- **Funding Liquidity**: **No immediate concerns** (positive operating cash flow; no capital raising indicated).  \n\n**No material information identified** beyond financials.",
  "usage": {
    "prompt_tokens": 3036,
    "completion_tokens": 242,
    "total_tokens": 3278,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T23:21:18.066246"
}